BR9713338A - Benzonaftiridinas como terapêuticos brÈnquicos. - Google Patents

Benzonaftiridinas como terapêuticos brÈnquicos.

Info

Publication number
BR9713338A
BR9713338A BR9713338-8A BR9713338A BR9713338A BR 9713338 A BR9713338 A BR 9713338A BR 9713338 A BR9713338 A BR 9713338A BR 9713338 A BR9713338 A BR 9713338A
Authority
BR
Brazil
Prior art keywords
benzonaphyridines
therapeutics
bronchial therapeutics
bronchial
brechanic
Prior art date
Application number
BR9713338-8A
Other languages
English (en)
Other versions
BR9713338B1 (pt
Inventor
Dieter Flockerzi
Karl-Josef Goebel
Beate Gutterer
Hermann Amschler
Wolf-Ruediger Ulrich
Thomas Martini
Thomas Baer
Armin Hatzelmann
Karl Sanders
Rolf Beume
Hildegard Boss
Dietrich Haefner
Hans-Peter Kley
Original Assignee
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab
Publication of BR9713338A publication Critical patent/BR9713338A/pt
Publication of BR9713338B1 publication Critical patent/BR9713338B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)

Abstract

Patente de Invenção: <B>"BENZONAFTIRIDINAS COMO TERAPêUTICOS BRÈNQUICOS"<D>. Os Compostos da fórmula (I) em que R1, R2, R3 e R4 têm os significados indicados na descrição são novos terapêuticos bronquiais ativos.
BRPI9713338-8A 1996-11-11 1997-11-05 benzonaftiridinas, medicamento, bem como seu uso como terapêuticos brÈnquicos. BR9713338B1 (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19646298 1996-11-11
EP96118188 1996-11-13
DE19739056 1997-09-05
PCT/EP1997/006096 WO1998021208A1 (en) 1996-11-11 1997-11-05 Benzonaphthyridines as bronchial therapeutics

Publications (2)

Publication Number Publication Date
BR9713338A true BR9713338A (pt) 2000-05-09
BR9713338B1 BR9713338B1 (pt) 2009-12-01

Family

ID=27216810

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9713338-8A BR9713338B1 (pt) 1996-11-11 1997-11-05 benzonaftiridinas, medicamento, bem como seu uso como terapêuticos brÈnquicos.

Country Status (30)

Country Link
US (1) US6008215A (pt)
EP (1) EP0937074B1 (pt)
JP (1) JP4223075B2 (pt)
KR (1) KR100484045B1 (pt)
CN (1) CN1090188C (pt)
AT (1) ATE234300T1 (pt)
AU (1) AU733129B2 (pt)
BG (1) BG63695B1 (pt)
BR (1) BR9713338B1 (pt)
CA (1) CA2270964C (pt)
CY (1) CY2476B1 (pt)
CZ (1) CZ288752B6 (pt)
DE (1) DE69719778T2 (pt)
DK (1) DK0937074T3 (pt)
EA (1) EA001551B1 (pt)
EE (1) EE03829B1 (pt)
ES (1) ES2195189T3 (pt)
GE (1) GEP20012390B (pt)
HU (1) HU226981B1 (pt)
ID (1) ID22042A (pt)
IL (1) IL129054A (pt)
NO (1) NO312764B1 (pt)
NZ (1) NZ334976A (pt)
PL (1) PL189641B1 (pt)
PT (1) PT937074E (pt)
RS (1) RS49607B (pt)
SI (1) SI0937074T1 (pt)
SK (1) SK283269B6 (pt)
TR (1) TR199900856T2 (pt)
WO (1) WO1998021208A1 (pt)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1075477T1 (en) 1998-05-05 2003-08-31 Altana Pharma Ag Novel Benzonaphthyridine-N-oxides
JP2002523505A (ja) * 1998-08-31 2002-07-30 ビイク グルデン ロンベルク ヒエーミツシエ フアブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング Ｐｄｅ３−及びｐｄｅ−４抑制作用を有するベンゾナフチリデン−ｎ−オキシド
IT1303272B1 (it) * 1998-10-29 2000-11-06 Zambon Spa Derivati triciclici inibitori della fosfodiesterasi 4
DE60033918D1 (de) 1999-01-15 2007-04-26 Altana Pharma Ag Polysubstituted 6-phenylphenanthridines mit pde-iv hemmender wirkung
WO2000042017A1 (en) * 1999-01-15 2000-07-20 Byk Gulden Lomberg Chemische Fabrik Gmbh Phenanthridine-n-oxides with pde-iv inhibiting activity
DE60024581T2 (de) * 1999-01-15 2006-08-10 Altana Pharma Ag 6-phenylphenanthridine mit pde-iv hemmender wirkung
CA2359449A1 (en) 1999-01-15 2000-07-20 Beate Gutterer Phenanthridine-n-oxides with pde-iv inhibiting activity
CA2715683A1 (en) * 1999-08-21 2001-03-01 Nycomed Gmbh Synergistic combination
NL1017973C2 (nl) * 2000-05-10 2002-11-08 Tristem Trading Cyprus Ltd Inrichting.
CA2438717C (en) * 2001-02-21 2011-08-30 Altana Pharma Ag 6-phenylbenzonaphthyridines
US6479493B1 (en) 2001-08-23 2002-11-12 Cell Pathways, Inc. Methods for treatment of type I diabetes
AU2003263216A1 (en) * 2002-08-17 2004-03-11 Nycomed Gmbh Benzonaphthyridines with PDE 3/4 inhibiting activity
HRP20050293A2 (en) 2002-09-04 2006-07-31 Altana Pharma Ag Novel benzonaphthyridines
JP4638736B2 (ja) * 2002-09-04 2011-02-23 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規のベンゾナフチリジン
EA200501548A1 (ru) 2003-04-01 2006-02-24 Апплайд Резеч Системз Арс Холдинг Н.В. Ингибиторы фосфодиэстераз при бесплодии
SG182194A1 (en) 2004-03-03 2012-07-30 Nycomed Gmbh Novel hydroxy-6-heteroarylphenanthridines and their use as pde4 inhibitors
AR049419A1 (es) * 2004-03-03 2006-08-02 Altana Pharma Ag Hidroxi-6-fenilfenantridinas sustituidas con heterociclilo
NZ549254A (en) * 2004-03-10 2010-06-25 Nycomed Gmbh Amido-substituted hydroxy-6-phenylphenanthridines and their use as PDE4 inhibitors
US7671068B2 (en) 2004-03-17 2010-03-02 Nycomed Gmbh N-(alkoxyalkyl) carbamoyl-substituted 6-phenyl-benzonaphthyridine derivatives and their use as PDE ¾ inhibitors
JP5009799B2 (ja) * 2004-09-08 2012-08-22 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規の３−オキサ−１０−アザ−フェナントレン
WO2006027345A2 (en) * 2004-09-08 2006-03-16 Altana Pharma Ag Novel 3-thia-10-aza-phenanthrene derivatives
SI1856093T1 (sl) 2005-03-02 2010-03-31 Nycomed Gmbh Hidrokloridna sol R aR bR dimetoksipiridin il etoksi metoksi a b heksahidrofenantridin ola
WO2007045979A1 (en) 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Pharmaceutical compositions of muscarinic receptor antagonists
TW200808695A (en) * 2006-06-08 2008-02-16 Amgen Inc Benzamide derivatives and uses related thereto
US7956064B2 (en) * 2006-09-01 2011-06-07 Cylene Pharmaceuticals, Inc. Fused tricyclic compounds as serine-threonine protein kinase and PARP modulators
JP5658138B2 (ja) 2008-04-23 2015-01-21 ライジェル ファーマシューティカルズ， インコーポレイテッド 代謝障害の処置のためのカルボキサミド化合物
AR079451A1 (es) 2009-12-18 2012-01-25 Nycomed Gmbh Compuestos 3,4,4a,10b-tetrahidro-1h-tiopirano[4,3-c]isoquinolina
CN108299429B (zh) * 2018-04-09 2021-10-08 中南大学 一类八氢苯并萘啶化合物及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3899494A (en) * 1970-05-13 1975-08-12 Sandoz Ltd Substituted 6-phenyl benzo-naphthyridines
EP0247971A3 (en) * 1986-05-29 1990-01-17 Sandoz Ag Novel pharmaceutical compositions comprising and use of cis-6-(4-acetanilido)-8,9-dimethoxy-2-methyl-1,2,3,4,4a,10b-hexahydrobenzo[c][1,6]naphthyridin
MY105344A (en) * 1990-05-16 1994-09-30 Byk Gulden Lomberg Chemische Fabrik New sulphonyl compounds

Also Published As

Publication number Publication date
HUP0000426A2 (hu) 2001-02-28
BG63695B1 (bg) 2002-09-30
SK283269B6 (sk) 2003-04-01
SK62399A3 (en) 1999-10-08
CZ288752B6 (cs) 2001-08-15
KR100484045B1 (ko) 2005-04-20
HUP0000426A3 (en) 2001-04-28
PT937074E (pt) 2003-07-31
EP0937074A1 (en) 1999-08-25
NO312764B1 (no) 2002-07-01
BR9713338B1 (pt) 2009-12-01
AU5317098A (en) 1998-06-03
BG103310A (en) 2000-05-31
DE69719778D1 (de) 2003-04-17
EE03829B1 (et) 2002-08-15
EA001551B1 (ru) 2001-04-23
ATE234300T1 (de) 2003-03-15
HU226981B1 (hu) 2010-04-28
NO992282D0 (no) 1999-05-11
PL189641B1 (pl) 2005-09-30
SI0937074T1 (en) 2003-08-31
JP4223075B2 (ja) 2009-02-12
DK0937074T3 (da) 2003-06-23
EE9900105A (et) 1999-10-15
JP2001503442A (ja) 2001-03-13
CY2476B1 (en) 2005-05-03
CN1236367A (zh) 1999-11-24
AU733129B2 (en) 2001-05-10
WO1998021208A1 (en) 1998-05-22
PL333429A1 (en) 1999-12-06
IL129054A (en) 2002-07-25
CZ167599A3 (cs) 1999-11-17
EP0937074B1 (en) 2003-03-12
TR199900856T2 (xx) 1999-07-21
CA2270964A1 (en) 1998-05-22
NZ334976A (en) 2000-10-27
DE69719778T2 (de) 2004-02-05
YU19499A (sh) 2001-09-28
ID22042A (id) 1999-08-26
ES2195189T3 (es) 2003-12-01
US6008215A (en) 1999-12-28
CN1090188C (zh) 2002-09-04
EA199900421A1 (ru) 1999-10-28
RS49607B (sr) 2007-06-04
NO992282L (no) 1999-05-11
CA2270964C (en) 2007-07-31
KR20000053100A (ko) 2000-08-25
GEP20012390B (en) 2001-03-25
HK1022151A1 (en) 2000-07-28
IL129054A0 (en) 2000-02-17

Similar Documents

Publication Publication Date Title
BR0007527A (pt) Fenilfenantridinas com atividade inibitória depde-iv
BR0010220A (pt) Compostos de pirimidinona
BR9916111A (pt) Derivados de fenilglicina
YU19499A (sh) Benzonaftiridini kao bronhijalni terapeutici
TR200102800T2 (tr) Yeni bileşikler.
BR9911040A (pt) 2-fenil-1-[4-(2-aminoetóxi)-benzil]-indol em combinação com estrogêneos
PT1140944E (pt) Derivados de epotilona e sua utilizacao como agentes antitumorais
PT896533E (pt) Pentafluorobenzenosulfonamidas e analogos
BR0108396A (pt) Derivados de pirimidina-4-0na como inibidores de ldl-pla(2)
ES2184077T3 (es) Nuevas fenantridinas sustituidas en la posicion 6.
DK0998460T3 (da) Hidtil ukendte tetrazolderivater
UY25712A1 (es) Benzamidas sustituidas y su aplicación en medicamentos
IT1285770B1 (it) Composti corticoidei
BR0014199A (pt) Derivados de bifenila como inibidores de nhe-3
YU11401A (sh) Lokalne farmaceutske kompozicije koje sadrže nimesulid
SE9801494D0 (sv) Novel use
AR020563A1 (es) Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion
BR9813719A (pt) Agentes terapêuticos
NO2019032I1 (no) Treosulfan
AP2001002188A0 (en) 5HT1 antagonists for antidepressant therapy.
BR9814188A (pt) &#34;agonistas de 5-ht1f&#34;
BR9912307A (pt) Inibidores fkbp
BR0114884A (pt) Compostos calcilìticos
AU7028798A (en) Use of 2-methylthiazolidine-2,4-dicarboxylic acid as mucolytic agent
BR0012329A (pt) Derivados de benzofurano

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: ALTANA PHARMA AG (DE)

Free format text: ALTERADO DE: BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B25D Requested change of name of applicant approved

Owner name: NYCOMED GMBH (DE)

Free format text: ALTERADO DE: ALTANA PHARMA AG

B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 01/12/2009, OBSERVADAS AS CONDICOES LEGAIS.

B25D Requested change of name of applicant approved

Owner name: TAKEDA GMBH (DE)

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 19A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2386 DE 27-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.